Aptose common shares to delist from Nasdaq
Source: SeekingAlpha
2025-04-01 08:46:03 ET
More on Aptose Biosciences
- Aptose Biosciences GAAP EPS of -$36.38
- Aptose Biosciences approves 1-for-30 reverse share split to restore Nasdaq compliance
- Seeking Alpha’s Quant Rating on Aptose Biosciences
- Historical earnings data for Aptose Biosciences
- Financial information for Aptose Biosciences
Read the full article on Seeking Alpha
For further details see:
Aptose common shares to delist from Nasdaq
Aptose Biosciences Inc.
NASDAQ: APTO
APTO Trading
-16.37% G/L:
$1.71 Last:
670,384 Volume:
$1.99 Open:
APTO Latest News
APTO Stock Data
$4,253,813
2,003,657
27.37%
8
69835%
Biotechnology & Life Sciences
Healthcare
CA
Toronto
